>>Signaling Pathways>> Endocrinology and Hormones>> Opioid Receptor>>LY-2940094

LY-2940094 (Synonyms: BTRX-246040)

Catalog No.GC36508

LY-2940094(BTRX-246040)는 높은 친화도(Ki\u003d0.105nM) 및 길항제 효능(Kb\u003d0.166nM)을 갖는 강력하고 선택적이고 경구적으로 이용 가능한 노시셉틴 수용체(NOP 수용체) 길항제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

LY-2940094 Chemical Structure

Cas No.: 1307245-86-8

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$191.00
재고 있음
5mg
US$180.00
재고 있음
10mg
US$315.00
재고 있음
25mg
US$630.00
재고 있음
50mg
US$810.00
재고 있음
100mg
US$1,272.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

LY-2940094 is a potent, selective and orally available nociceptin receptor (NOP receptor) antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY-2940094 reduces ethanol self-administration in animal models[1]. Ki: 0.105 nM (NOP receptor)[1]Kb: 0.166 nM (NOP receptor)[1]

LY-2940094 (LY2940094; 3, 10, or 30 mg/kg; 2-3 mL/kg; orally daily; for 4 days) dose-dependently reduces homecage ethanol self-administration in Indiana Alcohol-Preferring (P) and Marchigian Sardinian Alcohol-Preferring (msP) rats, without affecting food/water intake or locomotor activity[1]. Animal Model: Female Alcohol-Preferring (P) rats (250-320 g); Male Marchigian Sardinian Alcohol-Preferring (msP) rats (400-450 g)[1]

[1]. Rorick-Kehn LM, et al. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models. Alcohol Clin Exp Res. 2016 May;40(5):945-54.

리뷰

Review for LY-2940094

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for LY-2940094

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.